Evaluation of the Long-Term Impact on Quality After the End of Pharmacist-Driven Warfarin Therapy Management in Patients With Poor Quality of Anticoagulation Therapy

BACKGROUND: Warfarin is the most common oral anticoagulant drug, especially in low-income and emerging countries, because of the high cost of direct oral anticoagulant (DOACs), or when warfarin is the only proven therapy (mechanical prosthetic valve and kidney dysfunction). The quality of warfarin t...

Descripción completa

Detalles Bibliográficos
Autores principales: Marcatto, Leiliane Rodrigues, Sacilotto, Luciana, Tavares, Letícia Camargo, Souza, Debora Stephanie Pereira, Olivetti, Natália, Strunz, Celia Maria Cassaro, Darrieux, Francisco Carlos Costa, Scanavacca, Maurício Ibrahim, Krieger, Jose Eduardo, Pereira, Alexandre Costa, Santos, Paulo Caleb Junior Lima
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7381215/
https://www.ncbi.nlm.nih.gov/pubmed/32765269
http://dx.doi.org/10.3389/fphar.2020.01056

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7381215/
https://www.ncbi.nlm.nih.gov/pubmed/32765269
http://dx.doi.org/10.3389/fphar.2020.01056

Ejemplares similares